138 related articles for article (PubMed ID: 29982767)
1. Neonatal Murine Engineered Cardiac Tissue Toxicology Model: Impact of Metallothionein Overexpression on Cadmium-Induced Injury.
Yu H; Ye F; Yuan F; Cai L; Ji H; Keller BB
Toxicol Sci; 2018 Oct; 165(2):499-511. PubMed ID: 29982767
[TBL] [Abstract][Full Text] [Related]
2. Zinc protects against cadmium-induced toxicity in neonatal murine engineered cardiac tissues via metallothionein-dependent and independent mechanisms.
Yu HT; Zhen J; Xu JX; Cai L; Leng JY; Ji HL; Keller BB
Acta Pharmacol Sin; 2020 May; 41(5):638-649. PubMed ID: 31768045
[TBL] [Abstract][Full Text] [Related]
3. Neonatal murine engineered cardiac tissue toxicology model: Impact of dexrazoxane on doxorubicin induced injury.
Zhen J; Yu H; Ji H; Cai L; Leng J; Keller BB
Life Sci; 2019 Dec; 239():117070. PubMed ID: 31751580
[TBL] [Abstract][Full Text] [Related]
4. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein prevention of arsenic trioxide-induced cardiac cell death is associated with its inhibition of mitogen-activated protein kinases activation in vitro and in vivo.
Miao X; Tang Z; Wang Y; Su G; Sun W; Wei W; Li W; Miao L; Cai L; Tan Y; Liu Q
Toxicol Lett; 2013 Jul; 220(3):277-85. PubMed ID: 23664956
[TBL] [Abstract][Full Text] [Related]
6. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation.
Wang J; Song Y; Elsherif L; Song Z; Zhou G; Prabhu SD; Saari JT; Cai L
Circulation; 2006 Jan; 113(4):544-54. PubMed ID: 16432057
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity.
Liu Y; Liu J; Habeebu SM; Waalkes MP; Klaassen CD
Toxicol Sci; 2000 Sep; 57(1):167-76. PubMed ID: 10966523
[TBL] [Abstract][Full Text] [Related]
9. Absorption and distribution of cadmium in metallothionein-I transgenic mice.
Liu J; Klaassen CD
Fundam Appl Toxicol; 1996 Feb; 29(2):294-300. PubMed ID: 8742328
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein transgenic and knock-out mouse models in the study of cadmium toxicity.
Klaassen CD; Liu J
J Toxicol Sci; 1998 Jul; 23 Suppl 2():97-102. PubMed ID: 9760441
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the effects of overexpression of metallothionein-I in transgenic mice on the reproductive toxicology of cadmium.
Dalton T; Fu K; Enders GC; Palmiter RD; Andrews GK
Environ Health Perspect; 1996 Jan; 104(1):68-76. PubMed ID: 8834864
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein Preserves Akt2 Activity and Cardiac Function via Inhibiting TRB3 in Diabetic Hearts.
Gu J; Yan X; Dai X; Wang Y; Lin Q; Xiao J; Zhou S; Zhang J; Wang K; Zeng J; Xin Y; Barati MT; Zhang C; Bai Y; Li Y; Epstein PN; Wintergerst KA; Li X; Tan Y; Cai L
Diabetes; 2018 Mar; 67(3):507-517. PubMed ID: 29079702
[TBL] [Abstract][Full Text] [Related]
13. Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metallothionein-I/II null mice.
Liu J; Liu Y; Habeebu SM; Waalkes MP; Klaassen CD
Toxicology; 2000 Jul; 147(3):157-66. PubMed ID: 10924798
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein Prevents Age-Associated Cardiomyopathy via Inhibiting NF-κB Pathway Activation and Associated Nitrative Damage to 2-OGD.
Cong W; Niu C; Lv L; Ni M; Ruan D; Chi L; Wang Y; Yu Q; Zhan K; Xuan Y; Wang Y; Tan Y; Wei T; Cai L; Jin L
Antioxid Redox Signal; 2016 Dec; 25(17):936-952. PubMed ID: 27477335
[TBL] [Abstract][Full Text] [Related]
15. Cadmium modulates adipocyte functions in metallothionein-null mice.
Kawakami T; Nishiyama K; Kadota Y; Sato M; Inoue M; Suzuki S
Toxicol Appl Pharmacol; 2013 Nov; 272(3):625-36. PubMed ID: 23921151
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein protection of cadmium toxicity.
Klaassen CD; Liu J; Diwan BA
Toxicol Appl Pharmacol; 2009 Aug; 238(3):215-20. PubMed ID: 19362100
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice that overexpress metallothionein-I are protected from cadmium lethality and hepatotoxicity.
Liu Y; Liu J; Iszard MB; Andrews GK; Palmiter RD; Klaassen CD
Toxicol Appl Pharmacol; 1995 Dec; 135(2):222-8. PubMed ID: 8545831
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein overexpression in human trophoblastic cells protects against cadmium-induced apoptosis.
McAleer MF; Tuan RS
In Vitr Mol Toxicol; 2001; 14(1):25-42. PubMed ID: 11689154
[TBL] [Abstract][Full Text] [Related]
19. Cadmium toxicity and distribution in metallothionein-I and -II deficient transgenic mice.
Conrad CC; Walter CA; Richardson A; Hanes MA; Grabowski DT
J Toxicol Environ Health; 1997 Dec; 52(6):527-43. PubMed ID: 9397184
[TBL] [Abstract][Full Text] [Related]
20. Induction of c-myc and c-jun proto-oncogene expression in rat L6 myoblasts by cadmium is inhibited by zinc preinduction of the metallothionein gene.
Abshire MK; Buzard GS; Shiraishi N; Waalkes MP
J Toxicol Environ Health; 1996 Jul; 48(4):359-77. PubMed ID: 8691507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
